Literature DB >> 8417580

Antisocial personality disorder and HIV infection among intravenous drug abusers.

R K Brooner1, L Greenfield, C W Schmidt, G E Bigelow.   

Abstract

OBJECTIVE: Antisocial personality disorder in drug abusers has been associated with poor treatment outcome. The authors examined the relationship between diagnosis of antisocial personality and HIV infection.
METHOD: Subjects were 272 intravenous drug abusers, 140 (52%) of whom were in methadone treatment. Subjects were given an HIV risk behavior interview before diagnostic interviewing and HIV testing.
RESULTS: Using the DSM-III-R definition, the authors found that 119 (44%) of the subjects met criteria for antisocial personality. Significantly more of the subjects with antisocial personality (18% [N = 21] than of the subjects without antisocial personality (8% [N = 12]) had HIV infection. The diagnosis of antisocial personality disorder was associated with a significantly higher odds ratio of infection independent of ethnicity, gender, and treatment status.
CONCLUSIONS: Antisocial personality is a risk factor for HIV infection among intravenous drug abusers.

Entities:  

Mesh:

Year:  1993        PMID: 8417580     DOI: 10.1176/ajp.150.1.53

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

1.  Methadone programmes. The costs and benefits to society and the individual.

Authors:  G E Ralston; P Wilson
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

2.  Psychiatric diagnoses in a sample of HIV-infected people of color in methadone treatment.

Authors:  Mark G Winiarski; Lori I Greene; Alec L Miller; Nancy B Palmer; Jesus Salcedo; Maite Villanueva
Journal:  Community Ment Health J       Date:  2005-08

3.  The effect of a case management intervention on drug treatment entry among treatment-seeking injection drug users with and without comorbid antisocial personality disorder.

Authors:  Jennifer R Havens; Llewellyn J Cornelius; Erin P Ricketts; Carl A Latkin; David Bishai; Jacqueline J Lloyd; Steven Huettner; Steffanie A Strathdee
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

4.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

5.  Development and validation of short versions of the internal mental distress and behavior complexity scales in the Global Appraisal of Individual Needs (GAIN).

Authors:  Janet C Titus; Michael L Dennis; Richard Lennox; Christy K Scott
Journal:  J Behav Health Serv Res       Date:  2008-04       Impact factor: 1.505

6.  Interventions and Patterns of Risk in Adolescent HIV/AIDS Prevention.

Authors:  Robert M Malow; Rhonda Rosenberg; Geri Donenberg; Jessy G Dévieux
Journal:  Am J Infect Dis       Date:  2006

Review 7.  The Natural History of Antisocial Personality Disorder.

Authors:  Donald W Black
Journal:  Can J Psychiatry       Date:  2015-07       Impact factor: 4.356

8.  Using psychiatric symptomatology to assess risk for HIV infection in individuals with severe mental illness.

Authors:  Evan S Wu; Aileen Rothbard; Michael B Blank
Journal:  Community Ment Health J       Date:  2011-04-09

9.  HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.

Authors:  George E Woody; Douglas Bruce; P Todd Korthuis; Sumedha Chhatre; Sabrina Poole; Maureen Hillhouse; Petra Jacobs; James Sorensen; Andrew J Saxon; David Metzger; Walter Ling
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

10.  A behavioral treatment for opioid-dependent patients with antisocial personality.

Authors:  Karin J Neufeld; Michael S Kidorf; Kenneth Kolodner; Van L King; Michael Clark; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2007-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.